← Browse by Condition
Medical Condition

transthyretin cardiac amyloidosis

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4
NCT05772091
Recruiting

Prognostic Value of Echocardiographic Parameters Based on Machine Learning Approach

Enrollment
1,000 pts
Location
France
Sponsor
Pr. Nicolas GIRERD
View Trial →
NCT06328075
Recruiting

Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis

Enrollment
15,000 pts
Location
France
Sponsor
Algalarrondo Vincent
View Trial →
NCT05489523 Phase 4
Recruiting

Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation

Enrollment
25 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →